Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s12890-024-03001-0.

Title:
The role of colchicine in the management of COVID-19: a Meta-analysis | BMC Pulmonary Medicine
Description:
Background The Coronavirus disease 2019 (COVID-19) pandemic has robustly affected the global healthcare and economic systems and it was caused by coronavirus-2 (SARS-CoV-2). The clinical presentation of the disease ranges from a flu-like illness to severe pneumonia and death. Till September 2022, the cumulative number of cases exceeded 600 million worldwide and deaths were more than 6 million. Colchicine is an alkaloid drug that is used in many autoinflammatory conditions e.g., gout, familial Mediterranean fever, and Behçet’s syndrome. Colchicine inhibits the production of superoxide and the release of interleukins that stimulate the inflammatory cascade. Colchicine decreases the differentiation of myofibroblast and the release of fibrotic mediators including transforming growth factor (TGF-β1) that are related to the fibrosis. Moreover, colchicine has been used to traet viral myocarditis caused by CMV or EBV, interstitial pneumonia, and pericarditis resulting from influenza B infection. Additionally, colchicine is considered safe and affordable with wide availability. Objective The aim of the current study was to assess the evidence of colchicine effectiveness in COVID-19 treatment. Methods A comprehensive review of the literature was done till May 2022 and yielded 814 articles after ranking the articles according to authors and year of publication. Only 8 clinical trials and cohort studies fulfilling the inclusion criteria were included for further steps of data collection, analysis, and reporting. Results This meta-analysis involved 16,488 patients; 8146 patients in the treatment group and 8342 patients in the control group. The results showed that colchicine resulted in a significant reduction in the mortality rate among patients received colchicine in comparison with placebo or standard care (RR 0.35, 95%CI: 0.15–0.79). Colchicine resulted in a significant decrease in the need for O2 therapy in patients with COVID-19 (RR 0.07, 95%CI 0.02–0.27, P = 0.000024). However, colchicine had no significant effect on the following outcomes among COVID-19 patients: the need for hospitalization, ICU admission, artificial ventilation, and hospital discharge rate. Among the PCR confirmed COVID-19 patients, colchicine decreased the hospitalization rate (RR 0.75, 95%CI 0.57–0.99, P = 0.042). However, colchicine had no effect on mortality and the need for mechanical ventilation among this subgroup. Conclusion Colchicine caused a significant clinical improvement among COVID-19 patients as compared with the standard care or placebo, in terms of the need for O2, and mortality. This beneficial effect could play a role in the management of COVID-19 especially severe cases to decrease need for oxygen and to decrease mortality among these patients.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,016 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure how the site profits.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

colchicine, covid, patients, studies, article, efficacy, effect, mortality, pubmed, significant, clinical, google, scholar, study, data, analysis, metaanalysis, trials, table, rate, hospital, included, confirmed, coronavirus, treatment, results, ventilation, pcr, management, full, disease, showed, hospitalization, duration, cas, group, discharge, central, size, sarscov, illness, articles, cohort, pooled, fig, placebo, standard, artificial, recovery, tardif,

Topics {✒️}

mohamed farouk allam ain shams university tumor necrosis factor-α high-resolution ct chest mohamed nazmy farres cochrane central register article download pdf pcr-confirmed covid-19 patients alveolar-capillary oxygen transmission rasha samir google scholar proactive anti-inflammatory therapy mohamed nazmy keywords systematic review/meta-analysis privacy choices/manage cookies placebo-controlled clinical trial table 2 meta-analysis table 4 meta-analysis table 5 meta-analysis table 6 meta-analysis table 7 meta-analysis van den bruel illness till recovery mamani-garcía cs ct chest imaging jama netw open full access acute gouty arthritis versus standard treatment/placebo infectious respiratory droplets search strategy comprehensive search 17 full-text studies meta-analysis involved 16 recovery collaborative group full-text articles creative commons licence hospital discharge rate pcr–rt testing meta-analysis locating sars-cov-2 infection diabet metabol syndrome required robust efforts world health organization clotting factors occur named “autumn crocus” calculated unadjusted values lowering hospitalizations specifically detailed understanding highlights

Questions {❓}

  • Colchicine Against SARS-CoV-2 Infection: What is the Evidence?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The role of colchicine in the management of COVID-19: a Meta-analysis
         description:The Coronavirus disease 2019 (COVID-19) pandemic has robustly affected the global healthcare and economic systems and it was caused by coronavirus-2 (SARS-CoV-2). The clinical presentation of the disease ranges from a flu-like illness to severe pneumonia and death. Till September 2022, the cumulative number of cases exceeded 600 million worldwide and deaths were more than 6 million. Colchicine is an alkaloid drug that is used in many autoinflammatory conditions e.g., gout, familial Mediterranean fever, and Behçet’s syndrome. Colchicine inhibits the production of superoxide and the release of interleukins that stimulate the inflammatory cascade. Colchicine decreases the differentiation of myofibroblast and the release of fibrotic mediators including transforming growth factor (TGF-β1) that are related to the fibrosis. Moreover, colchicine has been used to traet viral myocarditis caused by CMV or EBV, interstitial pneumonia, and pericarditis resulting from influenza B infection. Additionally, colchicine is considered safe and affordable with wide availability. The aim of the current study was to assess the evidence of colchicine effectiveness in COVID-19 treatment. A comprehensive review of the literature was done till May 2022 and yielded 814 articles after ranking the articles according to authors and year of publication. Only 8 clinical trials and cohort studies fulfilling the inclusion criteria were included for further steps of data collection, analysis, and reporting. This meta-analysis involved 16,488 patients; 8146 patients in the treatment group and 8342 patients in the control group. The results showed that colchicine resulted in a significant reduction in the mortality rate among patients received colchicine in comparison with placebo or standard care (RR 0.35, 95%CI: 0.15–0.79). Colchicine resulted in a significant decrease in the need for O2 therapy in patients with COVID-19 (RR 0.07, 95%CI 0.02–0.27, P = 0.000024). However, colchicine had no significant effect on the following outcomes among COVID-19 patients: the need for hospitalization, ICU admission, artificial ventilation, and hospital discharge rate. Among the PCR confirmed COVID-19 patients, colchicine decreased the hospitalization rate (RR 0.75, 95%CI 0.57–0.99, P = 0.042). However, colchicine had no effect on mortality and the need for mechanical ventilation among this subgroup. Colchicine caused a significant clinical improvement among COVID-19 patients as compared with the standard care or placebo, in terms of the need for O2, and mortality. This beneficial effect could play a role in the management of COVID-19 especially severe cases to decrease need for oxygen and to decrease mortality among these patients.
         datePublished:2024-04-20T00:00:00Z
         dateModified:2024-04-20T00:00:00Z
         pageStart:1
         pageEnd:12
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12890-024-03001-0
         keywords:
            Coronavirus
            COVID-19
            SARS-CoV-2
            Colchicine
            Management
            Meta-analysis
            Ain Shams University
            Pneumology/Respiratory System
            Internal Medicine
            Intensive / Critical Care Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12890-024-03001-0/MediaObjects/12890_2024_3001_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12890-024-03001-0/MediaObjects/12890_2024_3001_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12890-024-03001-0/MediaObjects/12890_2024_3001_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12890-024-03001-0/MediaObjects/12890_2024_3001_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12890-024-03001-0/MediaObjects/12890_2024_3001_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12890-024-03001-0/MediaObjects/12890_2024_3001_Fig6_HTML.png
         isPartOf:
            name:BMC Pulmonary Medicine
            issn:
               1471-2466
            volumeNumber:24
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Kholoud Elshiwy
               affiliation:
                     name:Ain Shams University
                     address:
                        name:Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Ghada Essam El-Din Amin
               affiliation:
                     name:Ain Shams University
                     address:
                        name:Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
                        type:PostalAddress
                     type:Organization
                     name:Ain Shams University
                     address:
                        name:Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mohamed Nazmy Farres
               affiliation:
                     name:Ain Shams University
                     address:
                        name:Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rasha Samir
               affiliation:
                     name:Ain Shams University
                     address:
                        name:Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mohamed Farouk Allam
               affiliation:
                     name:Ain Shams University
                     address:
                        name:Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
                        type:PostalAddress
                     type:Organization
                     name:University of Cordoba
                     address:
                        name:Department of Preventive Medicine and Public Health, Faculty of Medicine, University of Cordoba, Cordoba, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The role of colchicine in the management of COVID-19: a Meta-analysis
      description:The Coronavirus disease 2019 (COVID-19) pandemic has robustly affected the global healthcare and economic systems and it was caused by coronavirus-2 (SARS-CoV-2). The clinical presentation of the disease ranges from a flu-like illness to severe pneumonia and death. Till September 2022, the cumulative number of cases exceeded 600 million worldwide and deaths were more than 6 million. Colchicine is an alkaloid drug that is used in many autoinflammatory conditions e.g., gout, familial Mediterranean fever, and Behçet’s syndrome. Colchicine inhibits the production of superoxide and the release of interleukins that stimulate the inflammatory cascade. Colchicine decreases the differentiation of myofibroblast and the release of fibrotic mediators including transforming growth factor (TGF-β1) that are related to the fibrosis. Moreover, colchicine has been used to traet viral myocarditis caused by CMV or EBV, interstitial pneumonia, and pericarditis resulting from influenza B infection. Additionally, colchicine is considered safe and affordable with wide availability. The aim of the current study was to assess the evidence of colchicine effectiveness in COVID-19 treatment. A comprehensive review of the literature was done till May 2022 and yielded 814 articles after ranking the articles according to authors and year of publication. Only 8 clinical trials and cohort studies fulfilling the inclusion criteria were included for further steps of data collection, analysis, and reporting. This meta-analysis involved 16,488 patients; 8146 patients in the treatment group and 8342 patients in the control group. The results showed that colchicine resulted in a significant reduction in the mortality rate among patients received colchicine in comparison with placebo or standard care (RR 0.35, 95%CI: 0.15–0.79). Colchicine resulted in a significant decrease in the need for O2 therapy in patients with COVID-19 (RR 0.07, 95%CI 0.02–0.27, P = 0.000024). However, colchicine had no significant effect on the following outcomes among COVID-19 patients: the need for hospitalization, ICU admission, artificial ventilation, and hospital discharge rate. Among the PCR confirmed COVID-19 patients, colchicine decreased the hospitalization rate (RR 0.75, 95%CI 0.57–0.99, P = 0.042). However, colchicine had no effect on mortality and the need for mechanical ventilation among this subgroup. Colchicine caused a significant clinical improvement among COVID-19 patients as compared with the standard care or placebo, in terms of the need for O2, and mortality. This beneficial effect could play a role in the management of COVID-19 especially severe cases to decrease need for oxygen and to decrease mortality among these patients.
      datePublished:2024-04-20T00:00:00Z
      dateModified:2024-04-20T00:00:00Z
      pageStart:1
      pageEnd:12
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12890-024-03001-0
      keywords:
         Coronavirus
         COVID-19
         SARS-CoV-2
         Colchicine
         Management
         Meta-analysis
         Ain Shams University
         Pneumology/Respiratory System
         Internal Medicine
         Intensive / Critical Care Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12890-024-03001-0/MediaObjects/12890_2024_3001_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12890-024-03001-0/MediaObjects/12890_2024_3001_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12890-024-03001-0/MediaObjects/12890_2024_3001_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12890-024-03001-0/MediaObjects/12890_2024_3001_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12890-024-03001-0/MediaObjects/12890_2024_3001_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12890-024-03001-0/MediaObjects/12890_2024_3001_Fig6_HTML.png
      isPartOf:
         name:BMC Pulmonary Medicine
         issn:
            1471-2466
         volumeNumber:24
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Kholoud Elshiwy
            affiliation:
                  name:Ain Shams University
                  address:
                     name:Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Ghada Essam El-Din Amin
            affiliation:
                  name:Ain Shams University
                  address:
                     name:Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
                     type:PostalAddress
                  type:Organization
                  name:Ain Shams University
                  address:
                     name:Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mohamed Nazmy Farres
            affiliation:
                  name:Ain Shams University
                  address:
                     name:Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rasha Samir
            affiliation:
                  name:Ain Shams University
                  address:
                     name:Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mohamed Farouk Allam
            affiliation:
                  name:Ain Shams University
                  address:
                     name:Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
                     type:PostalAddress
                  type:Organization
                  name:University of Cordoba
                  address:
                     name:Department of Preventive Medicine and Public Health, Faculty of Medicine, University of Cordoba, Cordoba, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:BMC Pulmonary Medicine
      issn:
         1471-2466
      volumeNumber:24
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Ain Shams University
      address:
         name:Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
         type:PostalAddress
      name:Ain Shams University
      address:
         name:Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
         type:PostalAddress
      name:Ain Shams University
      address:
         name:Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
         type:PostalAddress
      name:Ain Shams University
      address:
         name:Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
         type:PostalAddress
      name:Ain Shams University
      address:
         name:Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
         type:PostalAddress
      name:Ain Shams University
      address:
         name:Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
         type:PostalAddress
      name:University of Cordoba
      address:
         name:Department of Preventive Medicine and Public Health, Faculty of Medicine, University of Cordoba, Cordoba, Spain
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Kholoud Elshiwy
      affiliation:
            name:Ain Shams University
            address:
               name:Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Ghada Essam El-Din Amin
      affiliation:
            name:Ain Shams University
            address:
               name:Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
               type:PostalAddress
            type:Organization
            name:Ain Shams University
            address:
               name:Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
               type:PostalAddress
            type:Organization
      name:Mohamed Nazmy Farres
      affiliation:
            name:Ain Shams University
            address:
               name:Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
               type:PostalAddress
            type:Organization
      name:Rasha Samir
      affiliation:
            name:Ain Shams University
            address:
               name:Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
               type:PostalAddress
            type:Organization
      name:Mohamed Farouk Allam
      affiliation:
            name:Ain Shams University
            address:
               name:Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
               type:PostalAddress
            type:Organization
            name:University of Cordoba
            address:
               name:Department of Preventive Medicine and Public Health, Faculty of Medicine, University of Cordoba, Cordoba, Spain
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
      name:Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
      name:Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
      name:Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
      name:Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
      name:Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
      name:Department of Preventive Medicine and Public Health, Faculty of Medicine, University of Cordoba, Cordoba, Spain

External Links {🔗}(132)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.51s.